Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nawrocki, ST"'
Autor:
Carew JS; Division of Translational and Regenerative Medicine, Department of Medicine, The University of Arizona Comprehensive Cancer Center, Tucson, AZ., Espitia CM; Division of Translational and Regenerative Medicine, Department of Medicine, The University of Arizona Comprehensive Cancer Center, Tucson, AZ., Zhao W; Cancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX., Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Anwer F; Division of Hematology and Oncology, University of Arizona, Tucson AZ; and., Kelly KR; Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA., Nawrocki ST; Division of Translational and Regenerative Medicine, Department of Medicine, The University of Arizona Comprehensive Cancer Center, Tucson, AZ.
Publikováno v:
Blood advances [Blood Adv] 2019 Apr 23; Vol. 3 (8), pp. 1318-1329.
Autor:
Mahalingam D; Institute for Drug Development, Cancer Research and Therapy Centre at the University of Texas Health Science Centre, San Antonio, TX 78229, USA., Swords R, Carew JS, Nawrocki ST, Bhalla K, Giles FJ
Publikováno v:
British journal of cancer [Br J Cancer] 2009 May 19; Vol. 100 (10), pp. 1523-9. Date of Electronic Publication: 2009 Apr 28.
Autor:
Mahalingam D; Institute of Drug Development, Division of Cancer Research and Therapy Center, University of Texas Health Science Center, San Antonio, Texas, USA., Mita A, Mita MM, Nawrocki ST, Giles FJ
Publikováno v:
Current problems in cancer [Curr Probl Cancer] 2009 Mar-Apr; Vol. 33 (2), pp. 73-111.